1. Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS
2. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
3. Lineberger comprehensive cancer center, University of North Carolina, Chapel hill, North Carolina
4. Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, New York, USA